Article Sidebar
Views pdf: 8
PRIMARY HEPATIC ANGIOSARCOMA: A CASE REPORT
Main Article Content
Abstract
SUMMARY
We report a case who was diagnosed with primary hepatic angiosarcoma (PHA). A 62-year-old man presented with right upper quadrant abdominal pain, weight loss and hepatomegaly. He had no relevant medical history or exposure history. On laboratory evaluation, the patient had an elevation of white blood cell count, AST, ALT and anemia, the levels of serum carcinoembryonic antigen, carbohydrate antigen (CA)‑199, α‑fetoprotein and PIVKA-II were normal. Abdominal computed tomography and magnetic resonance imaging revealed a large lession in the right lobe of the liver and a small lesion in the left lobe of the liver suggesting PHA. The patient underwent liver biopsy and histopathological examination confirmed PHA.
PHA is a rare disease, usually occurs in the sixth decade of life and males are more frequently affected than females. In most cases, the cause is unknown. Clinical symptoms and laboratory evaluation of PHA are nonspecific. Imaging findings help detect liver tumors and suggest a diagnosis of PHA, in which CTA is the modality of choice. Liver biopsy and histopathology confirmed the presence of PHA.
Article Details
Keywords
angiosarcoma, primary hepatic angiosarcoma
References
2. Baxter PJ. The British hepatic angiosarcoma register. Environ Health Perspect. 1981 Oct;41:115-6.
3. Huang NC, Wann SR, Chang HT, Lin SL, Wang JS, Guo HR. Arsenic, vinyl chloride, viral hepatitis, and hepatic angiosarcoma: a hospital-based study and review of literature in Taiwan. BMC Gastroenterol. 2011 Dec 26;11:142.
4. Molina E, Hernandez A. Clinical manifestations of primary hepatic angiosarcoma. Dig Dis Sci. 2003 Apr;48(4):677-82.
5. Jiang L, Xie L, Li G, Xie H, Fang Z, Cai X, Chen Y. Clinical characteristics and surgical treatments of primary hepatic angiosarcoma. BMC Gastroenterol. 2021 Apr 7;21(1):156.
6. Wang ZB, Yuan J, Chen W, Wei LX. Transcription factor ERG is a specific and sensitive diagnostic marker for hepatic angiosarcoma. World J Gastroenterol. 2014 Apr 7;20(13):3672-9. 7. Locker GY, Doroshow JH, Zwelling LA, Chabner BA. The clinical features of hepatic angiosarcoma: a report of four cases and a review of the English literature. Medicine (Baltimore). 1979 Jan;58(1):48-64.
8. Chaudhary P, Bhadana U, Singh RA, Ahuja A. Primary hepatic angiosarcoma. Eur J Surg Oncol. 2015 Sep;41(9):1137-43.
9. Chen G, Li J, Wan R, Wang G, Shi J. Primary hepatic angiosarcoma in a 64-year-old man: A case report. Oncol Lett. 2016 Apr;11(4):2445-2448.
10. Wang L, Lv K, Chang XY, Xia Y, Yang ZY, Jiang YX, Dai Q, Tan L, Li JC. Contrast-enhanced ultrasound study of primary hepatic angiosarcoma: a pitfall of non-enhancement. Eur J Radiol. 2012 Sep;81(9):2054-9.
11. Yuan WH, Li AF, Hsu HC, Hu YS, Lee RC. Initial clinical radiological findings and staging to predict prognosis of primary hepatic angiosarcoma: A retrospective analysis. PLoS One. 2019 Nov 11;14(11):e0225043.
12. Rujeerapaiboon N, Wetwittayakhlang P. Primary Hepatic Angiosarcoma: A Rare Liver Malignancy - Varying Manifestations but Grave Prognosis. Case Rep Gastroenterol. 2020 Apr 8;14(1):137-149.
13. Kamatani T, Iguchi H, Okada T, et al. Co-registered positron emission tomography/computed tomography and gadolinium ethoxybenzyl-diethylenetriamine pentaacetic acid magnetic resonance imaging features of multiple angiosarcomas of the liver. Hepatol Res. 2013.
14. Bruegel M, Muenzel D, Waldt S, Specht K, Rummeny EJ. Hepatic angiosarcoma: cross-sectional imaging findings in seven patients with emphasis on dynamic contrast-enhanced and diffusion-weighted MRI. Abdom Imaging. 2013 Aug;38(4):745-54.
15. Moreiva RK, Washington K, In Lacobuzio-Donahue CA, Montgomery E. Gastrointestinal and liver pathology. 2nd ed., Elsevier Philadelphia, p666-667.